| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.00018 | 1 |